Øivind Foss
Direttore Tecnico/Scientifico/R&S presso ULTIMOVACS ASA
Posizioni attive di Øivind Foss
Società | Posizione | Inizio | Fine |
---|---|---|---|
ULTIMOVACS ASA | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Øivind Foss
Precedenti posizioni note di Øivind Foss
Società | Posizione | Inizio | Fine |
---|---|---|---|
Pharmalink Oncology AS | Direttore Tecnico/Scientifico/R&S | 01/05/2014 | - |
Smerud Medical Research International AS
Smerud Medical Research International AS BiotechnologyHealth Technology Smerud Medical Research International AS operates as drug development company and contract research organization. The firm specializes in proof-of-concept clinical trials and pivotal regulatory trials. It offers clinical operations, biostatistics, data management, regulatory affairs, medical writing, and consultation. The company was founded by Knut Terje Smerud in 1993 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - | - |
Formazione di Øivind Foss
Norwegian University of Science & Technology | Doctorate Degree |
Statistiche
Distribuzione geografica
Norvegia | 5 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Aziende private | 2 |
---|---|
Smerud Medical Research International AS
Smerud Medical Research International AS BiotechnologyHealth Technology Smerud Medical Research International AS operates as drug development company and contract research organization. The firm specializes in proof-of-concept clinical trials and pivotal regulatory trials. It offers clinical operations, biostatistics, data management, regulatory affairs, medical writing, and consultation. The company was founded by Knut Terje Smerud in 1993 and is headquartered in Oslo, Norway. | Health Technology |
Pharmalink Oncology AS |
- Borsa valori
- Insiders
- Øivind Foss
- Esperienza